• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
Levodopa

trade
type
Dopar©

Dopaminergic Agents
Levodopa

MOA
- Promote dopamine synthesis
- Prevent dopamine breakdown
-prevent dopaminergic drug breakdown
- Promote dopamine release
- Direct activation of dopamine receptors

Are for symptom relief & no way curative
Levodopa

results in dyskinesias
• tremor at rest,
• rigidity,
• postural instability,
• bradykinesia
Levodopa

Levodopa
-most common drug treat PD, used for symptom relief, no way curative
-works: crossing BBB & entering dopamine terminals within striatum where is converted into dopamine
-much converted/broken down before leaves periphery, so given with Carbidopa
Levodopa

Carbidopa
inhibits conversion of Levodopa in periphery
Parkinson’s:
-characterized by dyskinesia’s related to imbalance between dopamine & acetylcholine in striatum of extrapyramidal system
-is degeneration of neurons that supply dopamine to striatum in substantia nigra
-↑acetylcholine → ↑GABA: →dyskinesia’s common in PD
Benztropine

Trade
type
Cogentin©

Anticholinergic Agents
Benztropine

MOA
other sruff
- Blockade of muscarinic receptors in striatum
-Not 1st line PD treatment , reserved for EPS treatment caused by antipsychotics
-reduce tremors & rigidity, not bradykinesia
-blocks cholinergic receptors in periphery, causing
*dry mouth
*blurred vision, photophobia
*urinary retention, constipation
*tachycardia